تجاوز إلى المحتوى الرئيسي
drug protocol number
CICL670FIC05
drug sponsor
Novartis
drug study
deferasirox
drug trial site
King Abdulaziz University Hospital (Jeddah), Hereditary Blood Disease Center (al ahsa), King Abdulaziz Medical City NG (Riyadh)
drug status
Ongoing
drug phase